Please provide your email address to receive an email when new articles are posted on . Outset Medical Inc. reported in a recent 8-K filing that it had received a warning letter from the FDA ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis with its Tablo® Hemodialysis System, today ...

About a year after the company’s last distribution hold wrapped up, Outset Medical is once again pausing shipments of a component of its Tablo hemodialysis systems. This time around, the hold is ...

Detailed price information for Outset Medical Inc (OM-Q) from The Globe and Mail including charting and trades.

WHITMORE LAKE, Mich.--(BUSINESS WIRE)--Trace Medical, the national leader in advanced respiratory rentals and biomedical services, has announced a long-term distribution agreement with Outset Medical ...

Detailed price information for Outset Medical Inc (OM-Q) from The Globe and Mail including charting and trades.

“Outset’s results in the first quarter reflect the strong progress we have made with our commercial transformation, the durable competitive differentiation of Tablo for acute and home hemodialysis, ...

In its Q2 earnings release, Outset Medical Inc OM announced it has paused the shipment of TabloCart with Prefiltration, an accessory for the Tablo System, pending the FDA's clearance of a 510(k) the ...

Net revenue of $31.4 million grew 15% from the prior-year period, driven by a 25% increase in Tablo console revenue. Recurring revenue consisting of Tablo consumables and services grew 11% over the ...

Outset Medical, Inc. announced that it will release its financial results for the first quarter of 2025 on May 7, 2025, after market close. The company's Chair and CEO, Leslie Trigg, along with CFO ...